Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-24-001079
Filing Date
2024-02-12
Accepted
2024-02-12 16:01:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRIMECAP MANAGEMENT CO/CA/ fgena5_21224.htm SC 13G/A 26333
  Complete submission text file 0001085146-24-001079.txt   27840
Mailing Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105
Business Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105 6263049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

EIN.: 953868081
Type: SC 13G/A

Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Subject) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88653 | Film No.: 24619748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)